Block Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Allarity Therapeutics Inc

Change company Symbol lookup

Select an option...

ALLR Allarity Therapeutics Inc

SIVB SVB Financial Group

LYLT Loyalty Ventures Inc

NMRD Nemaura Medical Inc

LOGI Logitech International SA

BIOC Biocept Inc

KT KT Corp

SVRA Savara Inc

KA Kineta Inc

IMNM Immunome Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |

Company profile

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company. The Company is engaged in targeting some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates together with its Drug Response Predictor (DRP) companion diagnostics in a precision medicine approach. The Company's products include dovitinib, stenoparib, and IXEMPRA (ixabepilone). The lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. The therapeutic candidate is stenoparib is a novel inhibitor of the key deoxyribonucleic acid (DNA) damage repair enzyme poly-ADP-ribose polymerase (PARP). The therapeutic candidate is IXEMPRA (ixabepilone) is a selective microtubule inhibitor. The DRP technology is a diagnostic platform that models human tumor biology and can help predict whether a cancer patient respond or not to a particular drug.

Block Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

5:26 pm ET December 21, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Block Inc. (SQ) advanced 1.91% to $62.58 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.54% to 10,709.37 and the Dow Jones Industrial Average rising 1.60% to 33,376.48. This was the stock's second consecutive day of gains. Block Inc. closed $109.26 short of its 52-week high ($171.84), which the company reached on December 22nd.

The stock underperformed when compared to some of its competitors Wednesday, as OneSoft Solutions Inc. rose 2.27% to $0.33. Trading volume (7.8 M) remained 5.9 million below its 50-day average volume of 13.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 21, 2022.

(END) Dow Jones Newswires

December 21, 2022 17:26 ET (22:26 GMT)